Royal Bank of Canada
SPPI

Royal Bank of Canada’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Royal Bank of Canada’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed – – 7926
2023
Q2 		$0 Sell
4
-7,314
-100% -$7.23K ﹤0.01% 7895
2023
Q1 		$5K Buy
7,318
+6,594
+911% +$4.81K ﹤0.01% 6598
2022
Q4 		$0 Buy
724
+17
+2% +$7 ﹤0.01% 8006
2022
Q3 		$0 Buy
707
+661
+1,437% +$649 ﹤0.01% 8093
2022
Q2 		$0 Sell
46
-9,994
-100% -$8.81K ﹤0.01% 7957
2022
Q1 		$13K Sell
10,040
-23,951
-70% -$22.1K ﹤0.01% 6858
2021
Q4 		$43K Buy
33,991
+19,174
+129% +$34.3K ﹤0.01% 6459
2021
Q3 		$33K Buy
14,817
+4,225
+40% +$11.5K ﹤0.01% 6409
2021
Q2 		$40K Buy
10,592
+4,587
+76% +$15.9K ﹤0.01% 6194
2021
Q1 		$20K Sell
6,005
-28,824
-83% -$103K ﹤0.01% 6432
2020
Q4 		$119K Sell
34,829
-11,164
-24% -$45.9K ﹤0.01% 5237
2020
Q3 		$188K Buy
45,993
+10,604
+30% +$40.3K ﹤0.01% 4600
2020
Q2 		$120K Sell
35,389
-7,127
-17% -$20.8K ﹤0.01% 4745
2020
Q1 		$99K Buy
42,516
+30,217
+246% +$82.7K ﹤0.01% 4782
2019
Q4 		$44K Buy
12,299
+9,999
+435% +$80.8K ﹤0.01% 5513
2019
Q3 		$19K Sell
2,300
-19
-0.8% -$154 ﹤0.01% 5531
2019
Q2 		$20K Sell
2,319
-4,583
-66% -$41K ﹤0.01% 5730
2019
Q1 		$74K Buy
6,902
+4,602
+200% +$49.3K ﹤0.01% 4954
2018
Q4 		$20K Sell
2,300
-34,675
-94% -$442K ﹤0.01% 5593
2018
Q3 		$621K Buy
36,975
+2,934
+9% +$63.5K ﹤0.01% 3744
2018
Q2 		$713K Buy
34,041
+20,300
+148% +$376K ﹤0.01% 3498
2018
Q1 		$221K Sell
13,741
-600
-4% -$11.9K ﹤0.01% 4270
2017
Q4 		$272K Sell
14,341
-1,079,203
-99% -$19.5M ﹤0.01% 4233
2017
Q3 		$15.4M Buy
1,093,544
+411,430
+60% +$3.72M 0.01% 1256
2017
Q2 		$5.08M Sell
682,114
-33,137
-5% -$217K ﹤0.01% 1933
2017
Q1 		$4.65M Buy
715,251
+3,416
+0.5% +$19.1K ﹤0.01% 1963
2016
Q4 		$3.15M Sell
711,835
-147,063
-17% -$617K ﹤0.01% 2244
2016
Q3 		$4.01M Sell
858,898
-111,434
-11% -$660K ﹤0.01% 2060
2016
Q2 		$6.38M Buy
970,332
+62,428
+7% +$441K ﹤0.01% 1748
2016
Q1 		$5.77M Sell
907,904
-140,903
-13% -$723K ﹤0.01% 1731
2015
Q4 		$6.32M Buy
1,048,807
+30,476
+3% +$174K ﹤0.01% 1719
2015
Q3 		$6.09M Sell
1,018,331
-1,876
-0.2% -$13K ﹤0.01% 1465
2015
Q2 		$6.98M Buy
1,020,207
+4,359
+0.4% +$27.7K ﹤0.01% 1405
2015
Q1 		$6.17M Sell
1,015,848
-15,034
-1% -$100K ﹤0.01% 1468
2014
Q4 		$7.14M Buy
1,030,882
+26,675
+3% +$196K ﹤0.01% 1418
2014
Q3 		$8.17M Sell
1,004,207
-37,911
-4% -$297K 0.01% 1323
2014
Q2 		$8.47M Buy
1,042,118
+21,693
+2% +$165K 0.01% 1314
2014
Q1 		$8M Sell
1,020,425
-152,632
-13% -$1.29M 0.01% 1279
2013
Q4 		$10.4M Buy
1,173,057
+1,162,749
+11,280% +$10.4M 0.01% 1169
2013
Q3 		$86K Sell
10,308
-2,200
-18% -$17.8K ﹤0.01% 4561
2013
Q2 		$93K Buy
+12,508
New +$96K ﹤0.01% 4351

Royal Bank of Canada's SPPI Position: Q3 2023 in Review

Royal Bank of Canada sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 4 shares.

Royal Bank of Canada first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $15.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Royal Bank of Canada reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 4 Spectrum Pharmaceuticals Inc shares in Q3 2023.
  • Royal Bank of Canada first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
  • Royal Bank of Canada's Spectrum Pharmaceuticals Inc position peaked at $15.4M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.